Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

J. J. Body, I. J. Diel, M. R. Lichinitser, E. D. Kreuser, W. Dornoff, V. A. Gorbunova, M. Budde, B. Bergström, J. S. de Gréve, I. Mancini, S. Van Belle, F. Cavalli, B. Thuerlimann, R. Herrmann, M. Clemens, W. Eiermann, G. Kaiser, P. Nauen, R. Obenaus, A. E. SchindlerA. Vogt, K. Hoeffken, L. M. Ahlemann, U. Essers, V. G. Porta, J. M. Ferrero, P. Pouillard, A. de Gramont, N. Pinon, S. Reme, J. P. Labat, L. Guillevin, J. F. Morere, C. Krzisch, Z. Mechl, O. Bruland, O. K. Andersen, R. Bremnes, E. P. Ferreira, A. Fernandes, H. Bassara, V. F. Semiglazov, J. Hansen, I. Lorenz, A. Howell, D. Cameron, C. J. Tyrell, T. J. Powels, J. McAleer, P. J. Barrett-Lee, K. Cash, J. Craig, D. A. Decker, R. Gams, R. Gottlieb, R. Gucalp, A. Hage-Boutros, K. Havlin, J. Hon, J. Gale Katterhagen, M. Lewis, T. Panella, P. Plezia, S. Rivkin, J. Sandbach, J. Wade, P. Woolley, P. Conkling, T. J. Ervin, M. Martinez-Rio, D. Tripathy, M. Meshad, J. P. Jordaan, I. D. Werner, G. Falkson

Research output: Contribution to journal › Article › peer-review

378 Scopus citations

Fingerprint

Dive into the research topics of 'Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases'. Together they form a unique fingerprint.

Medicine & Life Sciences